1-13 of 13
Shufen Cao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

African American Race Is a Potential Favorable Biologic Factor That Impacts Clinical Outcome for Patients with Multiple Myeloma

Jeries Kort, Leland Metheny, Pingfu Fu, Shufen Cao, James J. Driscoll, Ehsan Malek
Journal: Blood
Blood (2022) 140 (Supplement 1): 7244–7245.
https://doi.org/10.1182/blood-2022-170717
Published: 2022
Journal Articles

A Longitudinal Evaluation of Cytopenia Severity in Patients with Clonal Cytopenia of Undetermined Significance (CCUS) and Correlation with the Presence of Sub-Clinical Dysplasia

Michael Daunov, Howard Meyerson, Kwadwo Asare Oduro, Jr., Christopher B Ryder, Navid Sadri, Jennifer Yoest, Shufen Cao, Pingfu Fu, Rose Beck, Benjamin Tomlinson
Journal: Blood
Blood (2021) 138 (Supplement 1): 3705.
https://doi.org/10.1182/blood-2021-153506
Published: 2021
Journal Articles

Prognostic Value of Dynamic Monoclonal Protein Pattern on Probability of Myeloma Progression from the Precursor State

Jeries Kort, Ravikumar Kyasaram, Shufen Cao, Pingfu Fu, James J. Driscoll, Ehsan Malek
Journal: Blood
Blood (2021) 138 (Supplement 1): 3781.
https://doi.org/10.1182/blood-2021-153265
Published: 2021
Journal Articles

Towards CD177 As a Predictive Biomarker for Hypomethylating Agent Response in Myelodysplastic Syndrome

James Ignatz-Hoover, Pingfu Fu, Shufen Cao, Benjamin Tomlinson, Howard Meyerson
Journal: Blood
Blood (2021) 138 (Supplement 1): 4665.
https://doi.org/10.1182/blood-2021-153761
Published: 2021
Journal Articles

Development of a Risk Score for Cardiovascular Events in Anthracycline Treated DLBCL Patients

Akiva Diamond, Sabarish Ayyappan, Shufen Cao, Nour Tashtish, Kirsten M Boughan, Brenda W. Cooper, Pingfu Fu, Paolo F. Caimi
Journal: Blood
Blood (2021) 138 (Supplement 1): 2536.
https://doi.org/10.1182/blood-2021-153862
Published: 2021
Journal Articles

Health Care Burden of Monogammopathy of Renal Significance

Jeries Kort, MD, Paolo F Caimi, MD, Pingfu Fu, PhD, Shufen Cao, James Driscoll, Marcos de Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 34–36.
https://doi.org/10.1182/blood-2020-139740
Published: 2020
Journal Articles

Risk of Secondary Malignancy in CLL Patients Treated with Novel Targeted Agents

Anna Eversman, Shufen Cao, Kirsten M Boughan, DO, Molly M Gallogly, MDPhD, Ehsan Malek, MD, Leland Metheny, III, MD, Timothy E. O'Brien, MD, Folashade Otegbeye, MBBChir,MPH, Brenda W. Cooper, MD, Pingfu Fu, Marcos de Lima, MD, Paolo F Caimi, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 46–47.
https://doi.org/10.1182/blood-2020-140042
Published: 2020
Journal Articles

Low Dose Daily Corticosteroid Tapering Regimen Allows Highly Effective and Practical Desensitization for Multiple Myeloma Patients with Skin Rash after Immunomodulatory Drugs

Amin Firoozmand, MD, Naveed Ali, MD, Nausheen Ahmed, MD, Pingfu Fu, Shufen Cao, George Brown, Hannah Schmikla, RN, James J. Driscoll, MD PhD, Timothy O'Brien, Paolo Caimi, MD, Marcos de Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-140800
Published: 2020
Journal Articles

Stem Cell Transplant Minimizes Insurance Coverage-Driven Outcomes Disparities for Multiple Myeloma Patients

Gayathri Ravi, MD, Kamal Chamoun, MD, Kirsten M Boughan, DO, Shufen Cao, Pingfu Fu, Marcos de Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 424.
https://doi.org/10.1182/blood-2019-126131
Published: 2019
Journal Articles

Filgrastim Administered after Early Assessment Bone Marrow Biopsy during 7+3 Induction Therapy for Acute Myeloid Leukemia Reduces Length of Hospital Stay

Jiasheng Wang, MD, Kirsten M Boughan, DO, Paolo F Caimi, MD, Brenda Cooper, MD, Marcos de Lima, MD, Molly M Gallogly, MD PhD, Ehsan Malek, MD, Leland Metheny, III, MD, Folashade Otegbeye, MBBChir,MPH, Shufen Cao, Pingfu Fu, PhD, Benjamin Tomlinson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2607.
https://doi.org/10.1182/blood-2019-131293
Published: 2019
Journal Articles

Outcomes after Treatment with Upfront Cyclophosphamide or Rituximab for Initial Acquired Thrombotic Thrombocytopenic Purpura

Mouhamed Yazan Abou-Ismail, MD, Yasmin Arafah, MD, Pingfu Fu, PhD, Shufen Cao, Alvin H. Schmaier, MD, Lalitha V. Nayak, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1084.
https://doi.org/10.1182/blood-2019-123537
Published: 2019
Journal Articles

Lymphoma-Specific Venous Thromboembolism Score (LyV-Score): Use of Lymphoma Subtype to Refine Risk Prediction

Shufen Cao, Gouri Dharmavaram, Kirsten M Boughan, DO, Brenda Cooper, MD, Molly M Gallogly, MD PhD, Ehsan Malek, MD, Leland Metheny, III, MD, Folashade Otegbeye, MBBChir,MPH, Benjamin K. Tomlinson, MD, Marcos de Lima, MD, Pingfu Fu, Paolo F Caimi, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4770.
https://doi.org/10.1182/blood-2019-131527
Published: 2019
Journal Articles

The Prognostic Factors for Early Fatal Outcome in Patients with Multiple Myeloma

Sowjanya Vuyyala, MD, Kamal Chamoun, MD, Pingfu Fu, Shufen Cao, Molly M Gallogly, MD PhD, Marcos de Lima, MD, Ehsan Malek, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 270.
https://doi.org/10.1182/blood-2019-126156
Published: 2019